Morgan Stanley’s Northwest Biotherapeutics, Inc. Common stock NWBO Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2016
Q4 | – | Sell |
-213,755
| Closed | -$116K | – | 6734 |
|
|
2016
Q3 | $116K | Sell |
213,755
-16,423
| -7% | -$8.91K | ﹤0.01% | 5251 |
|
|
2016
Q2 | $134K | Sell |
230,178
-86,720
| -27% | -$50.5K | ﹤0.01% | 5112 |
|
|
2016
Q1 | $462K | Sell |
316,898
-38,865
| -11% | -$56.7K | ﹤0.01% | 4500 |
|
|
2015
Q4 | $1.14M | Buy |
355,763
+125,694
| +55% | +$402K | ﹤0.01% | 3960 |
|
|
2015
Q3 | $1.44M | Sell |
230,069
-66,254
| -22% | -$414K | ﹤0.01% | 3805 |
|
|
2015
Q2 | $2.94M | Buy |
296,323
+94,502
| +47% | +$939K | ﹤0.01% | 3262 |
|
|
2015
Q1 | $1.49M | Sell |
201,821
-76,658
| -28% | -$565K | ﹤0.01% | 3830 |
|
|
2014
Q4 | $1.49M | Buy |
278,479
+43,093
| +18% | +$231K | ﹤0.01% | 3805 |
|
|
2014
Q3 | $1.18M | Buy |
235,386
+17,172
| +8% | +$86.4K | ﹤0.01% | 3899 |
|
|
2014
Q2 | $1.46M | Buy |
218,214
+5,554
| +3% | +$37.3K | ﹤0.01% | 3735 |
|
|
2014
Q1 | $1.54M | Buy |
212,660
+179,711
| +545% | +$1.3M | ﹤0.01% | 3647 |
|
|
2013
Q4 | $124K | Buy |
+32,949
| New | +$124K | ﹤0.01% | 5264 |
|